tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Francois Brisebois, 127 are a BUY (92.7%), 10 are a HOLD (7.3%).
Analyst Francois Brisebois, currently employed at LIFESCI, carries an average stock price target met ratio of 46.7% that have a potential upside of 41.54% achieved within 244 days. Previously, Francois Brisebois worked at OPPENHEIMER.
Francois Brisebois’s has documented 262 price targets and ratings displayed on 35 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AQST, Aquestive Therapeutics at 08-Sep-2025.
Analyst best performing recommendations are on DMTK (DERMTECH).
The best stock recommendation documented was for DMTK (DERMTECH) at 1/22/2021. The price target of $53 was fulfilled within 14 days with a profit of $10.08 (23.49%) receiving and performance score of 16.78.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$20
$-1.49 (-6.93%)
$20
1 months 15 days ago
(28-Oct-2025)
5/6 (83.33%)
$1.41 (7.58%)
266
Buy
$20
$-1.49 (-6.93%)
$36
1 months 20 days ago
(23-Oct-2025)
2/3 (66.67%)
$1.44 (7.76%)
71
Buy
$19
1 months 21 days ago
(22-Oct-2025)
34/34 (100%)
$9.61 (102.34%)
365
Buy
$21
$-0.49 (-2.28%)
$21
9 months 9 days ago
(04-Mar-2025)
8/14 (57.14%)
$13.36 (174.87%)
472
Buy
$22
$0.51 (2.37%)
$30
11 months 3 days ago
(10-Jan-2025)
11/15 (73.33%)
$14.1 (178.48%)
713
Which stock is Francois Brisebois is most bullish on?
Which stock is Francois Brisebois is most reserved on?
What Year was the first public recommendation made by Francois Brisebois?
